LOGIN  |  REGISTER
Terns Pharmaceuticals
Astria Therapeutics

Medical Facilities to Announce Third Quarter 2023 Financial Results on November 9, 2023

October 26, 2023 | Last Trade: C$16.23 0.00 0.00

TORONTO, Oct. 26, 2023 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities" or "MFC") will release its third quarter 2023 financial results prior to market open on Thursday, November 9, 2023. MFC's financial statements and management's discussion and analysis for the three-month period ended September 30, 2023 will be filed on SEDAR+ at www.sedarplus.ca following the release, and will be available on the same day on MFC's website at www.medicalfacilitiescorp.ca. Management will host an earnings conference call to review the financial results at 8:30 a.m. ET the same morning.

Earnings Call Dial in Instructions

Interested parties may join the conference call by dialing 1-877-550-1875 approximately 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins. A question-and-answer session will follow management's prepared remarks, at which time the operator will provide instructions to qualified equity analysts for submitting questions.

Webcast Registration

A live audio webcast of the call will be available at https://bit.ly/MFC2023Q3. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on MFC's website following the call date.

About Medical Facilities Corporation

Medical Facilities, in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASC specializes in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.

Chimerix

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page